Nodal-staging surgery for locally advanced cervical cancer in the era of PET

The Lancet Oncology

Volumn 13, Issue 5, 2012, Pages

  Gouy, Sebastien ^a   Morice, Philippe ^a,c   Narducci, Fabrice ^b   Uzan, Catherine ^a   Gilmore, Jennifer ^a   Kolesnikov Gauthier, Hélène ^b   Querleu, Denis ^d   Haie Meder, Christine ^a   Leblanc, Eric ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE OSCAR LAMBRET   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; PACLITAXEL;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; DISEASE FREE SURVIVAL; DOSIMETRY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FALSE NEGATIVE RESULT; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LAPAROTOMY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER;

AORTA, ABDOMINAL; CHEMORADIOTHERAPY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 84860427542     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70011-6     Document Type: Review

References (83)

1. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008, 26:5802-5812. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration.
2. Morice P, Castaigne D, Pautier P, et al. Interest of pelvic and para-aortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 1999, 73:106-110.
3. Kidd EA, Siegel BA, Dehdashti F, et al. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol 2010, 28:2108-2113.
4. Leblanc E, Narducci F, Frumovitz M, et al. Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging in locally advanced cervical carcinoma. Gynecol Oncol 2007, 105:304-311.
5. Michel G, Morice P, Castaigne D, Leblanc M, Rey A, Duvillard P Lymphatic spread in stage Ib and II cervical carcinoma: anatomy and surgical implications. Obstet Gynecol 1998, 91:360-363.
6. Grigsby PW, Siegel BA, Dehdashti F Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001, 19:3745-3749.
7. Choi HJ, Ju C, Myung SK, Kim Y Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computed tomography for the detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis. Cancer Sci 2010, 101:1471-1479.
8. Brockbank E, Kokka F, Bryant A, Pomel C, Reynolds K Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer. Cochrane Database Syst Rev 2011, 4. CD008217.
9. Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 2001, 218:776-782.
10. Selman TJ, Mann C, Zamora J, Appleyard TL, Khan K Diagnostic accuracy of tests for lymph nodes status in primary cervical cancer: a systematic review and meta-analysis. CMAJ 2008, 178:855-862.
11. Rockall AG, Sohaib SA, Harisinghani MG, et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 2005, 23:2813-2821.
12. Choi EK, Kim JK, Choi HJ, et al. Node-by-node correlation between MR and PET/CT in patients with uterine cervical cancer: diffusion-weighted imaging versus size-based criteria on T2WI. Eur Radiol 2009, 19:2024-2032.
13. Liu Y, Liu H, Bai X, et al. Differentiation of metastatic from non-metastatic lymph nodes in patients with uterine cervical cancer using diffusion-weighted imaging. Gynecol Oncol 2011, 122:19-24.
14. Havrilesky LJ, Lasingam SL, Mathar DB, Myers ER FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol 2005, 97:183-191.
15. Chou HH, Chang HP, Lai CH, et al. (18)F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma. Eur J Nucl Med Mol Imaging 2010, 37:728-735.
16. Kitajima K, Suzuki K, Senda M, et al. Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone. Ann Nucl Med 2011, 25:511-519.
17. Kang S, Kim SK, Chung DC, et al. Diagnostic value of 18F-FDG PET for evaluation of paraaortic nodal metastasis in patients with cervical carcinoma: a meta-analysis. J Nucl Med 2010, 51:360-367.
18. Kim SK, Choi HJ, Park SY, et al. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients. Eur J Cancer 2009, 45:2103-2109.
19. Uzan C, Souadka A, Gouy S, et al. Analysis of morbidity and clinical implications of laparoscopic paraaortic lymphadenectomy in a continuous series of 98 patients with advanced-stage cervical cancer and negative PET-CT imaging in the paraaortic area. Oncologist 2011, 16:1021-1027.
20. Leblanc E, Gauthier H, Querleu D, et al. Accuracy of 18-fluoro-2-deoxy-D:-glucose positron emission tomography in the pretherapeutic detection of occult paraaortic node involvement in patients with a locally advanced cervical carcinoma. Ann Surg Oncol 2011, 18:2302-2309.
21. Ramirez PT, Jhingran A, Macapinlac HA, et al. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer 2011, 117:1928-1934.
22. Mortier DG, Stroobants S, Amant F, Neven P, Van Limbergen E, Vergote I Laparoscopic para-aortic lymphadenectomy and positron emission tomography scan as staging procedures in patients with cervical carcinoma stage IB2-IIIB. Int J Gynecol Cancer 2008, 18:723-729.
23. Yildirim Y, Sehirali S, Avci ME, et al. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings. Gynecol Oncol 2008, 108:154-159.
24. Loft A, Berthelsen AK, Roed H, et al. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol 2007, 106:29-34.
25. Lin WC, Hung YC, Yeh LS, Kao CH, Yen RF, Shen YY Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. Gynecol Oncol 2003, 89:73-76.
26. Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 1999, 17:41-45.
27. Delgado G, Chun B, Caglar H, Bepko F Paraaortic lymphadenectomy in gynecologic malignancies confined to the pelvis. Obstet Gynecol 1977, 50:418-423.
28. Nelson JH, Boyce J, Macasaet M, et al. Incidence, significance, and follow-up of para-aortic lymph node metastases in late invasive carcinoma of the cervix. Am J Obstet Gynecol 1977, 128:336-340.
29. Belinson JL, Goldberg MI, Averette HE Paraaortic lymphadenectomy in gynecologic cancer. Gynecol Oncol 1979, 7:188-198.
30. Querleu D, Dargent D, Ansquer Y, Leblanc E, Narducci F Extraperitoneal endosurgical aortic dissection in the staging of advanced carcinomas of the cervix. Cancer 2000, 88:1883-1891.
31. Rafii A, Camicas A, Ferron G, et al. A comparative study of laparoscopic extraperitoneal laparoscopy with the use of ultrasonically activated shears. Am J Obstet Gynecol 2009, 201:370 e1. 370 e5.
32. Benedetti-Panici PL, Maneschi F, Scambia G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 1996, 62:19-24.
33. Possover M, Krause N, Drahonovsky J, Schneider A Left-sided suprarenal retrocrural paraaortic lymphadenectomy in advanced cervical cancer by laparoscopy. Gynecol Oncol 1998, 71:219-222.
34. Vergote I, Amant F, Berteloot P, Van Gramberen M Laparoscopic lower paraaortic staging lymphadenectomy in stage IB2, II, and III cervical cancer. Int J Gynecol Cancer 2002, 12:22-26.
35. Merlot B, Narducci F, Ferron G, et al. Do we need to extend the para-aortic lymphadenectomy above the level of the inferior mesenteric artery in locally advanced cervical cancers? Presented at the 17th International Meeting of the European Society of Gynaecological Oncology (ESGO); Milan, Italy; Sept 11-14, 2011.
36. Buchsbaum HJ Extrapelvic lymph node metastases in cervical carcinoma. Am J Obstet Gynecol 1979, 133:814-824.
37. LaPolla, Schlaerth JB, Gaddis O, Morrow CP The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma. Gynecol Oncol 1986, 24:194-206.
38. Weiser EB, Bundy BN, Hoskins WJ, et al. Extraperitoneal versus transperitoneal selective paraaortic lymphadenectomy in the pretreatment surgical staging of advanced cervical carcinoma (a Gynecologic Oncology Group study). Gynecol Oncol 1989, 33:283-289.
39. Holcomb K, Abulafia O, Matthews RP, Gabbur N, Lee YC, Buhl A The impact of pretreatment staging laparotomy on survival in locally advanced cervical carcinoma. Eur J Gynaecol Oncol 1999, 20:90-93.
40. Odunsi KO, Lele S, Ghamande S, Seago P, Driscoll DL The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer. Eur J Gynaecol Oncol 2001, 22:325-330.
41. Hasenburg A, Salama JK, Van TJ, Amosson C, Chiu JK, Kieback DG Evaluation of patients after extraperitoneal lymph node dissection and subsequent radiotherapy for cervical cancer. Gynecol Oncol 2002, 84:321-326.
42. Denschlag D, Gabriel B, Mueller-Lantzsch C, et al. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer. Gynecol Oncol 2005, 96:658-664.
43. Moore KN, Gold MA, McMeekin DS, Walker JL, Rutledge T, Zorn KK Extraperitoneal paraaortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes. Gynecol Oncol 2008, 108:466-471.
44. Recio FO, Piver MS, Hempling RE Pretreatment transperitoneal laparoscopic staging pelvic and paraaortic lymphadenectomy in large (≥5 cm) stage IB2 cervical carcinoma: report of a pilot study. Gynecol Oncol 1996, 63:333-336.
45. Vidaurreta J, Bermúdez A, di Paola G, Sardi J Laparoscopic staging in locally advanced cervical carcinoma: a new possible philosophy?. Gynecol Oncol 1999, 75:366-371.
46. Dargent D, Ansquer Y, Mathevet P Technical development and results of left extraperitoneal laparoscopic paraaortic lymphadenectomy for cervical cancer. Gynecol Oncol 2000, 77:87-92.
47. Hertel H, Köhler C, Elhawary T, Michels W, Possover M, Schneider A Laparoscopic staging compared with imaging techniques in the staging of advanced cervical cancer. Gynecol Oncol 2002, 87:46-51.
48. Tillmanns T, Lowe MP Safety, feasibility, and costs of outpatient laparoscopic extraperitoneal aortic nodal dissection for locally advanced cervical carcinoma. Gynecol Oncol 2007, 106:370-374.
49. Fichez A, Lamblin G, Mathevet P Left extraperitoneal laparoscopic paraaortic lymphadenectomy: morbidity and learning curve of the technique. Gynecol Obstet Fertil 2007, 35:990-996.
50. Gil-Moreno A, Franco-Camps S, Cabrera S, et al. Pretherapeutic extraperitoneal laparoscopic staging of bulky or locally advanced cervical cancer. Ann Surg Oncol 2011, 18:482-489.
51. Occelli B, Narducci F, Lanvin D, et al. De novo adhesions with extraperitoneal endosurgical para-aortic lymphadenectomy versus transperitoneal laparoscopic para-aortic lymphadenectomy: a randomized experimental study. Am J Obstet Gynecol 2000, 183:529-533.
52. Füller J, Guderian D, Köhler C, Schneider A, Wendt TG Lymph edema of the lower extremities after lymphadenectomy and radiotherapy for cervical cancer. Strahlenther Onkol 2008, 184:206-211.
53. Ohba Y, Todo Y, Kobayashi N, et al. Risk factors for lower-limb lymphedema after surgery for cervical cancer. International journal of clinical oncology. Int J Clin Oncol 2011, 16:238-243.
54. Yenen MC, Dede M, Alanbay I, Ustün Y, Gültekin M, Ayhan A Port-site metastasis after laparoscopic extraperitoneal paraaortic lymphadenectomy for stage IIb squamous cell carcinoma of the cervix. J Minim Invasive Gynecol 2009, 16:227-230.
55. Park JY, Lim MC, Lim SY, et al. Port-site and liver metastases after laparoscopic pelvic and paraaortic lymph node dissection for surgical staging of locally advanced cervical cancer. Int J Gynecol Oncol 2008, 18:176-180.
56. Fine BA, Hempling RE, Piver MS, Baker TR, McAuley M, Driscoll D Severe radiation morbidity in carcinoma of the cervix: impact of pretherapy surgical staging and previous surgery. Int J Radiat Oncol Biol Phys 1995, 31:717-723.
57. Benk V, Przybysz R, McGowan T, Paszat L Waiting times for radiation therapy in Ontario. Can J Surg 2006, 49:16-21.
58. Wyatt RM, Beddoe AH, Dale RG The effects of delays in radiotherapy treatment on tumour control. Phys Med Biol 2003, 48:139-155.
59. Mackillop W, Fu H, Quirt CF, Dixon P, Brundage M, Zhou Y Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 1994, 30:221-228.
60. Marnitz S, Köhler C, Roth C, Füller J, Hinkelbein W, Schneider A Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?. Gynecol Oncol 2005, 99:536-544.
61. Höckel M, Horn L-C, Manthey N, et al. Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol 2009, 10:683-692.
62. Piver MS, Barlow JJ, Krishnamsetty R Five-year survival (with no evidence of disease) in patients with biopsy-confirmed aortic node metastasis from cervical carcinoma. Am J Obstet Gynecol 1981, 139:575-578.
63. Podczaski E, Stryker JA, Kaminski P, et al. Extended-field radiation therapy for carcinoma of the cervix. Cancer 1990, 66:251-258.
64. Malfetano JH, Keys H Aggressive multimodality treatment for cervical cancer with paraaortic lymph node metastases. Gynecol Oncol 1991, 42:44-47.
65. Husseinzadeh N, Shrake P, DeEulis T, Rowley K, Aron B Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: a phase II pilot study. Gynecol Oncol 1994, 52:326-331.
66. Grigsby PW, Lu JD, Mutch DG, Kim RY, Eifel PJ Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: phase II study of the Radiation Therapy Oncology Group 92-10. Int J Radiat Oncol Biol Phys 1998, 41:817-822.
67. Grigsby PW, Heydon K, Mutch DG, Kim RY, Eifel P Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 2001, 51:982-987.
68. Varia MA, Bundy BN, Deppe G, et al. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy-a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1998, 42:1015-1023.
69. Small W, Winter K, Levenback C, et al. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys 2007, 68:1081-1087.
70. Kim YS, Kim JH, Ahn SD, et al. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 2009, 74:1522-1528.
71. Walker JL, Morrison A, DiSilvestro P, von Gruenigen VE A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: a Gynecologic Oncology Group study. Gynecol Oncol 2009, 112:78-84.
72. Loiselle C, Koh WJ The emerging use of IMRT for treatment of cervical cancer. J Natl Compr Canc New 2010, 8:1425-1434.
73. Chen CC, Lin JC, Jan JS, et al. Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer. Gynecol Oncol 2011, 122:9-13.
74. Kavanagh BD, Schefter TE, Wu Q, et al. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol 2002, 12:260-271.
75. Ahmed RS, Kim RY, Duan J, et al. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk. Int J Radiat Oncol Biol Phys 2004, 60:505-512.
76. Esthappan J, Chaudhari S, Santanam L, et al. Prospective clinical trial of positron emission tomography computed tomography image-guided intensity-modulated radiation therapy for cervical carcinoma with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 2008, 72:1134-1139.
77. Gerszten K, Colonello K, Heron DE Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. Gynecol Oncol 2006, 102:182-188.
78. Kidd EA, Siegel BA, Dehdashti F, et al. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2010, 77:1085-1091.
79. Mutic S, Malyapa RS, Grigsby PW, et al. PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes: a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys 2003, 55:28-35.
80. Salama JK, Mundt AJ, Roeske J, Mehta N Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 2006, 65:1170-1176.
81. Lai CH, Huang KG, Hong JH, et al. Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol 2003, 89:160-167.
82. Gold MA, Tian C, Whitney CW, Rose PG, Lanciano R Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study. Cancer 2008, 112:1954-1963.
83. Ghezzi F, Cromi A, Serati M, et al. Radiation-induced bowel complications: laparoscopic versus open staging of gynecologic malignancy. Ann Surg Oncol 2011, 18:782-791.